NanditaKheraMD
Oncology • Scottsdale, AZHematologic Oncology
Assistant Professor, Internal Medicine, Mayo Medical School
Dr. Khera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13400 E. Shea Blvd
Scottsdale, AZ 85259- Is this information wrong?
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2011
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2005 - 2008
Lady Hardinge Medical CollegeClass of 2001
Certifications & Licensure
AZ State Medical License 2011 - 2025
WA State Medical License 2008 - 2012
PA State Medical License 2005 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE) Start of enrollment: 2014 Aug 29
- Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant Patients Start of enrollment: 2018 May 22
Publications & Presentations
PubMed
- Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.Nandita Khera, Marie Louise Edwards, Yan Song, Rochelle Sun, Rocio Manghani, Heayoung Shin, Ronit Simantov, James Signorovitch, Smitha Sivaraman, Usama Gergis> ;Advances in Therapy. 2024 Apr 1
- Family-Focused Facilitated Fitness: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and The...Shelby L Langer, Rodney P Joseph, Erin G Mistretta, Chun Tao, Laura S Porter, Allison S Campos, Nandita Khera> ;Transplantation and Cellular Therapy. 2024 Apr 1
- 3 citationsVenetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxi...Omer Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek Mang...> ;American Journal of Hematology. 2024 Feb 1
- Join now to see all
Lectures
- Excitement for CAR-T, but Not Its Price TagMayo School of Continuous Professional Development, Phoenix, Arizona - 9/15/2012
- Current practice for screening and management of financial distress at NCCN member institutions.2019 ASCO Annual Meeting - 6/1/2019
- Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- Excitement for CAR-T, but Not Its Price TagFebruary 2020
Press Mentions
Equity, Quality, and Remote Care Focus of 19 Newly Funded Delivery Science Research InitiativesApril 27th, 2022- Negative Impact of Medical Expenses High Among Patients with ASCVD, CancerJune 24th, 2021
- Mayo Clinic Research in the News — 6/21/2021June 21st, 2021
- Join now to see all
Hospital Affiliations
Mayo Clinic HospitalPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
